Emicizumab versus immunosuppressive therapy for the management of ac-quired hemophilia A.

Hart C, Klamroth R, Sachs UJ, Greil R, Knoebl P, Oldenburg J, Miesbach W, Pfrepper C, Trautmann-Grill K, Pekrul I, Holstein K, Eichler H, Weigt C, Schipp D, Werwitzke S, Tiede A.

J Thromb Haemost. 2024 Jun 25:S1538-7836(24)00368-4. doi: 10.1016/j.jtha.2024.06.010. Online ahead of print. PMID: 38936699.

https://pubmed.ncbi.nlm.nih.gov/38936699/